Arab Americans & Lung Cancer Research

Intervention Research with the Middle Eastern/Arab Americans to Reduce and Eliminate Disparities

Smoking and Lung Cancer

Metropolitan Detroit has the largest population of Middle Eastern/Arab Americans numbering more than 400,000 residents. Given the growing practice of water pipe (WP) smoking, especially among Arab American adolescents, Dr. Rice and colleagues are studying the little known effects of such risk behavior. Compared to cigarette smokers, they expect that WP smoking significantly diminishes lung function and increases health problems among youth. They also expect to see differing patterns, frequency, and intensity of WP use, yet similar or worse health problems as outcomes. The study sites include three public high schools in the Karmanos' catchment area. A detailed water pipe and cigarette smoking "lifetime" history of tobacco use has been obtained from nearly 3000 high school seniors. The 300 students with the longest and most severe water pipe and/or cigarette smoking histories have been asked to participate in saliva cotinine testing (to verify their smoking status) and pulmonary function testing. These students will be compared with nonsmokers matched on key pulmonary function variables (age, gender, height, and ethnicity). The analyses will estimate the effects of smoking status on spirometry outcomes.

  • Lead Researcher: Dr. Rice

The Latest From Karmanos Cancer Institute

News

Research and Breakthroughs: Community Conversations on Cancer Delivers Collaborative Dialogue with Community on Latest Cancer Treatments

The Barbara Ann Karmanos Cancer Institute’s Office of Community Outreach and Engagement (COE) has continued its Community Conversations on Cancer ...

Read More

IN THE NEWS - Second Opinion Saves Lives: A Prostate Cancer Survivor’s Journey

WDIV Not satisfied with just having surgery as the only treatment option, Terrell Thomas came to Karmanos Cancer Institute for a second opinion fo...

Read More

Karmanos Researcher Co-discovered Compound, Led to First FDA-Approved Therapy for Rare Brain Cancer

For Gen Sheng Wu, Ph.D., a member of the Molecular Therapeutics Research Program at the Barbara Ann Karmanos Cancer Institute and professor in the...

Read More
News

105.9 KISS FM | Getting a Second Opinion at Karmanos

Listen Now

WJR | Karmanos Cancer Institute Continues Its Community Education Series

Listen Now

WXYT 97.1 The Ticket | ‘Get a Mammogram’

Listen Now